Siemens DCA Vantage HbA1C Analyzer, CLIA Waived


(No reviews yet) Write a Review



Product Overview

DCA Vantage AnalyzerDrive diabetic patient compliance with trusted, clinically proven results

The DCA Vantage® Analyzer is a multi-parameter, point-of-care analyzer for monitoring glycemic control in patients with diabetes and detecting early kidney disease.

  • CLIA-waived HbA1c test that is IFCC and NGSP-certified
  • 1µl finger stick without fasting – HbA1c results in 6 minutes
  • Random urine sample provides A:C ratio in 7 minutes
  • Requires no sample or reagent preparation prior to testing

Features & Benefits

Easy to use and implement

  • Plug and play installation
  • Simple, one-step calibration scan with every new lot
  • Guided user-interface with step-by-step testing instructions
  • Hassle-free maintenance

Improve patient outcomes and operational costs

  • Increase patient satisfaction when testing during office visit1
  • Aid in lowering HbA1c levels over time2,3
  • Reduce costs associated with post-visit testing1
  • Satisfy HbA1c and kidney check HEDIS quality measures

Failsafe measures for audit risk mitigation

  • QC lockout prevents patient testing if QC not tested or fails
  • Prevent unauthorized users from testing and accessing confidential patient information
  • Eliminate transcription errors with bar-code data entry and automatic transmission of results
  • Link patient results to operators and material lot information (audit-ready)
  • Customizable operator-specific system access mode

Results you can trust

  • Robust reagent cartridges designed to minimize pre-analytical errors associated with sample and reagent handling
  • Consistently meet NGSP and IFCC annual certifications for HbA1c
  • Clinically proven to correlate with lab methods4,5


(No reviews yet) Write a Review